covid vaccine pfizer - Search News

Order byBest matchMost fresh

FDA, Covid and vaccines

Digest more

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

The new labels will expand that warning to certain age groups.

· 1d · on MSN

· 2d · on MSN

FDA expands COVID vaccine warning about possible side effect

· 1d

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

FDA panel recommends keeping COVID shots targeted to same strain as last year

Advisers to the Food and Drug Administration have recommended COVID-19 vaccine makers continue to target their shots to the so-called JN.1 coronavirus strain for the upcoming fall and winter seasons, ...

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

STAT · 4h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 5h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Pfizer scientist claimed COVID vax results being delayed until after 2020 election ‘wasn’t a coincidence’: House GOP panel

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public

21hon MSN

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,

2don MSN

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.

F.D.A. Poised to Restrict Access to Covid Vaccines

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many others may not be able to get the shots.

CIDRAP4d

Data show slight increase in menstrual length after COVID vaccines

Overall, women who received a COVID vaccine had a 19% greater risk of increase in menstrual cycle length as compared to unvaccinated women or women in pre-vaccination time periods (summary relative risk [sRR], 1.19; 95% confidence interval [CI], 1.11 to 1.26).

Asianet Newsable on MSN4d

Novavax Wins FDA Approval For COVID-19 Vaccine: Retail Calls For Buyback And Bigger Moves

The pharma company secured FDA clearance to manufacture and distribute its COVID-19 vaccine Nuvaxovid for adults and at-risk groups, with no advisory committee hurdles.